Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.
Original text from hospital filings
Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Argyle, TX
See all hospitals reporting HCPCS Q2042 →Price type
Medical City Argyle’s median price of $1325.5k is 113% above the median hospital's median price ($621.3k), higher than 91% of the 1,166 hospitals reporting HCPCS Q2042. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.
Last updated: Mar 1, 2026
See CAR-T cell therapy infusion, per dose pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.